Latest News about Joel Latham
Recent news which mentions Joel Latham
Incannex Secures $60M Financing To Drive Advances In Psychedelic And Cannabinoid Therapies
September 10, 2024
Tickers
IXHL
From Benzinga
Fortrea To Manage Incannex's FDA IND Opening Phase 2/3 Trial Of Its Dronabinol-Based Drug For Obstructive Sleep Apnea
July 18, 2023
From Benzinga
Incannex Stock Trading Higher On Entering A Lease For First Psychedelic-Assisted Psychotherapy Clinic
May 05, 2023
Tickers
IXHL
From Benzinga
Incannex Engages Catalent For Development And Manufacture Of Psilocybin Drug For Clinical Trials
March 03, 2023
From Benzinga
Psychedelics And Virtual Reality Treatment Developed By Monash University, Funded By Incannex
March 03, 2022
Tickers
IXHL
From Benzinga